Skip to main content
TipRanks
Go Ultimate75% OFF

Minerva Neurosciences (NERV) Ratios

625 Followers

Minerva Neurosciences Ratios

NERV's free cash flow for Q3 2026 was $-8.15M. For the 2026 fiscal year, NERV's free cash flow was increased by $0.00 and operating cash flow was $-8.15M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio36.297.8512.5729.1522.07
Quick Ratio36.297.8512.5729.1522.07
Cash Ratio35.947.5312.2526.2021.55
Solvency Ratio-1.230.02-0.35-0.43-0.72
Operating Cash Flow Ratio-5.90-6.89-4.43-17.89-8.73
Short-Term Operating Cash Flow Coverage0.000.000.000.000.00
Net Current Asset Value$ -155.62M$ -40.57M$ -43.35M$ -34.95M$ -6.94M
Leverage Ratios
Debt-to-Assets Ratio0.660.000.000.000.00
Debt-to-Equity Ratio-0.460.000.000.000.00
Debt-to-Capital Ratio-0.860.000.000.000.00
Long-Term Debt-to-Capital Ratio-0.860.000.000.000.00
Financial Leverage Ratio-0.70-1.45-2.00-2.759.67
Debt Service Coverage Ratio0.001.32-2.62-3.33-6.87
Interest Coverage Ratio0.00-4.79-2.79-3.41-7.17
Debt to Market Cap1.910.000.000.000.00
Interest Debt Per Share7.680.601.271.391.18
Net Debt to EBITDA0.06-3.551.891.461.34
Profitability Margins
Gross Profit Margin0.00%0.00%0.00%0.00%0.00%
EBIT Margin0.00%0.00%0.00%0.00%0.00%
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Profit Margin0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT100.00%100.00%100.00%100.00%96.51%
EBT Per EBIT1942.82%-6.59%129.78%127.26%113.98%
Return on Assets (ROA)-299.51%3.87%-52.73%-58.29%-64.71%
Return on Equity (ROE)208.47%-5.60%105.44%160.35%-625.73%
Return on Capital Employed (ROCE)-15.79%-63.69%-43.17%-46.98%-61.05%
Return on Invested Capital (ROIC)-15.79%-63.69%-43.17%-46.98%-58.93%
Return on Tangible Assets-353.10%6.46%-71.42%-79.92%-80.23%
Earnings Yield-862.37%8.56%-74.99%-378.17%-145.80%
Efficiency Ratios
Receivables Turnover0.000.000.000.000.00
Payables Turnover0.000.000.000.000.00
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover0.000.000.000.000.00
Asset Turnover0.000.000.000.000.00
Working Capital Turnover Ratio0.000.000.000.000.00
Cash Conversion Cycle0.000.000.000.000.00
Days of Sales Outstanding0.000.000.000.000.00
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding0.000.000.000.000.00
Operating Cycle0.000.000.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-1.60-2.58-2.27-4.62-4.61
Free Cash Flow Per Share-1.60-2.58-2.27-4.62-4.61
Dividend Paid and CapEx Coverage Ratio0.000.000.00-1509.560.00
Capital Expenditure Coverage Ratio0.000.000.00-1509.560.00
Operating Cash Flow Coverage Ratio-0.210.000.000.000.00
Operating Cash Flow to Sales Ratio0.000.000.000.000.00
Free Cash Flow Yield-39.71%-116.35%-36.95%-290.46%-71.87%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-0.1211.68-1.33-0.26-0.69
Price-to-Sales (P/S) Ratio0.000.000.000.000.00
Price-to-Book (P/B) Ratio-0.24-0.65-1.41-0.424.29
Price-to-Free Cash Flow (P/FCF) Ratio-2.52-0.86-2.71-0.34-1.39
Price-to-Operating Cash Flow Ratio-2.52-0.86-2.71-0.34-1.39
Price-to-Earnings Growth (PEG) Ratio0.00-0.110.060.010.00
Enterprise Value Multiple-0.06-0.760.041.120.59
Enterprise Value16.69M-4.56M-900.67K-27.60M-26.53M
EV to EBITDA-0.06-0.760.041.120.59
EV to Sales0.000.000.000.000.00
EV to Free Cash Flow-1.230.230.061.121.08
EV to Operating Cash Flow-1.230.230.061.121.08
Tangible Book Value Per Share-18.39-5.36-6.66-6.54-1.30
Shareholders’ Equity Per Share-16.63-3.39-4.37-3.751.49
Tax and Other Ratios
Effective Tax Rate0.000.000.000.000.03
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-34.670.19-4.61-6.01-9.35
Tax Burden1.001.001.001.000.97
Interest Burden1.000.241.381.301.14
Research & Development to Revenue0.000.000.000.000.00
SG&A to Revenue0.000.000.000.000.00
Stock-Based Compensation to Revenue0.000.000.000.000.00
Income Quality0.05-13.590.490.770.49

Currency in USD